Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Advanced Solid Tumors 4Solid Tumors 2Unspecified Adult Solid Tumor, Protocol Specific 1Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 15atezolizumab 11Gemcitabine 11Carboplatin 9pembrolizumab 8Docetaxel 8Bevacizumab 8Irinotecan 7Injections 6Cetuximab 6Capecitabine 6Sunitinib 5Leucovorin 5Fluorouracil 5Cyclophosphamide 5tocilizumab 4pazopanib 4olaparib 4navitoclax 4liposomal doxorubicin 4Topotecan 4Oxaliplatin 4Nivolumab 4Erlotinib Hydrochloride 4temsirolimus 3spartalizumab 3lenvatinib 3fludarabine 3cobimetinib 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solid Tumors × Panobinostat × Other solid neoplasm × Clear all
NCT00550199 2013-08-19

LBH589 and Gemcitabine in the Treatment of Solid Tumors

SCRI Development Innovations, LLC

Phase 1 Terminated
17 enrolled
Other solid neoplasm

Solid Tumors

NCT00556088 2010-12-30

LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors

SCRI Development Innovations, LLC

Phase 1 Completed
40 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡